Purity, ID & Quantitation
View the analytical report assigned to this product option.
View COA↗Imagine First
WOLVERINE
WOLVERINE
Regular price
$79.00
Regular price
Sale price
$79.00
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
WOLVERINE is a two-peptide research blend containing BPC-157 and TB-500. Each vial is formulated as an equal blend—half BPC-157 and half TB-500—based on the selected total vial content, for controlled laboratory investigation of this combined research profile.
Supplied in lyophilized dry-powder form and clearly labeled for laboratory use.
For laboratory research use only. Not for human or veterinary use.
Documentation
Certificate of Analysis
Select a product option to view its available documentation.
Endotoxin
View the endotoxin report assigned to this product option.
View COA↗Documentation applies only to the product option and lot identified in each report.
Research overview
Two peptide research materials in one equal-part blend.
WOLVERINE combines BPC-157 and TB-500 in equal proportions. Published sources below provide component-level research context; the combined material requires its own experimental validation.
BPC-157A synthetic 15-amino-acid peptide investigated primarily in preclinical tissue, vascular-signaling, and connective-tissue models.
TB-500A market research name associated with thymosin beta-4-related peptide material and actin-regulation research.
Equal blendHalf of the labeled total peptide content is BPC-157 and half is TB-500.
Research nameWOLVERINE
CompositionHalf BPC-157 / Half TB-500
Presentation10MG
Material formLyophilized powder
Compound Profile & Technical Overview
WOLVERINE is an equal-part blend of two synthetic peptide research materials: BPC-157 and TB-500. BPC-157 is a defined 15-residue sequence studied mainly in laboratory and animal models. TB-500 is a market research name associated with thymosin beta-4-related material; that name alone does not establish an exact sequence or equivalence to full-length thymosin beta-4. The selected lot's analytical documentation is the controlling source for component identity, ratio, purity, measured content, and endotoxin results. Research on either component alone does not establish the behavior, safety, efficacy, or expected outcome of this combined material.
Storage requirements
Protect from lightKeep refrigerated after reconstitutionAvoid freeze/thaw cycles
Lyophilized powder-20°CStated stability: 24+ months
Reconstituted solution2-8°CStated stability: approximately 30 days
Sealed lyophilized vials are described as heat-stable; refrigeration or freezing of sealed vials is optional. The 2-8°C guidance applies after reconstitution. Always follow the lot-specific documentation when it differs.
Published Research & References
BPC-157 research resources: experimental Achilles-tendon model, experimental ligament-healing model, and VEGFR2-Akt-eNOS signaling research. Thymosin beta-4 research resources: experimental wound-healing research and actin-interaction research. These are component-level sources. Thymosin beta-4 findings do not by themselves establish the identity or equivalence of independently supplied TB-500, and none of these studies establishes outcomes for the WOLVERINE blend.
Important research notice
This material is offered strictly for laboratory research use. It is not intended for human or veterinary use, food use, compounding, diagnosis, treatment, cure, or prevention of disease. Neither component is represented here as an approved drug. Published findings are provided only as educational research context and do not establish equivalence to, or expected results from, this independently supplied blend.
FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN OR VETERINARY USE · NOT A DRUG, FOOD, COSMETIC, OR MEDICAL PRODUCT